Improving exercise rehabilitation for Veterans with peripheral artery disease
Official title: Improving exercise rehabilitation efficacy and outcomes in Veterans with peripheral artery disease: Targeting oxidative stress and inflammation
Funded at VA Salt Lake City Healthcare System · NIH-10869935 · Data updated 2026-11-12
This study is looking to improve exercise rehabilitation for Veterans with peripheral artery disease (PAD) by understanding how factors like oxidative stress and inflammation affect their ability to exercise, so we can create better treatments that help them get moving again.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Salt Lake City Healthcare System NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | July 1, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| NIH project number | 5IK2RX003913-02 |
| Project ID | NIH-10869935 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Veterans diagnosed with peripheral artery disease who experience exercise intolerance.
✕Less likely to help
Patients without peripheral artery disease or those who do not have a history of cardiovascular issues may not benefit from this research.
What this research studies
This research focuses on enhancing the effectiveness of exercise rehabilitation for Veterans suffering from peripheral artery disease (PAD), a condition that severely limits blood flow and exercise tolerance. The study aims to identify the underlying mechanisms of exercise intolerance, particularly the roles of oxidative stress and inflammation in PAD. By investigating these factors, the research seeks to develop targeted interventions that can improve blood flow and mitochondrial function, ultimately leading to better rehabilitation outcomes for patients. Veterans, who are at a higher risk for PAD due to various health factors, will be the primary focus of this investigation.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and exercise capacity for Veterans with peripheral artery disease.
How similar studies have gone: Previous research has shown that targeting oxidative stress and inflammation can lead to improved outcomes in similar patient populations, suggesting a promising avenue for this investigation.
Where this research is happening
-
VA Salt Lake City Healthcare System
Salt Lake City, United States Active
Researchers
- Principal investigator: Craig, Jesse Charles — VA Salt Lake City Healthcare System
- Study coordinator: Craig, Jesse Charles
Related research
Other NIH-funded projects on the same topics.
-
Investigating how microRNA-210 affects oxidative stress in patients with peripheral artery disease
This study is looking at how a tiny molecule called microRNA-210 affects muscle health in people with peripheral artery disease (PAD) and how it might help doctors create better, personalized treatments for patients after they have surgery to improve blood flow.
-
Low-dose colchicine to reduce vascular risk in people with peripheral artery disease
This project tests whether taking a low-dose anti-inflammatory drug (colchicine) daily can lower heart and limb-related risks for adults with peripheral artery disease.
-
How vitamin B12 helps the gum-disease bacterium survive
Learning how vitamin B12 helps the bacteria that cause gum disease survive and become more harmful for people with periodontitis.
-
Gamified home walking program to help seniors with peripheral artery disease improve walking and quality of life
A program uses game elements on wearable devices to help people 65+ with peripheral artery disease walk more at home and feel better.
-
Pancreatic beta cells, oxidative stress, and gestational diabetes
A study is exploring how oxidative stress and changes in pancreatic beta cells during pregnancy may contribute to gestational diabetes and future diabetes risk for both mother and baby.
-
Environmental air pollutants linked to preeclampsia risk in pregnancy
This study looks at whether common air pollutants called PAHs increase the risk of preeclampsia during pregnancy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.